Coherus Biosciences | Le Bénéfice D'Exploitation



Operating Profit Changement Date
AbbVie USD 3.73B 5.22B 2025-03
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -16755000 35.77M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Baxter International USD -435000000 590M 2024-12
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Fujifilm JPY 106.88B 19.2B 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 5.87B 1.57B 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Pacira USD 1.99M 22.71M 2025-03
Perrigo USD 79.4M 33.3M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Xencor USD -43183000 47.23M 2025-03
Zoetis USD 810M 78M 2025-03



Coherus Biosciences Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.